ZIHIPP LTD

08341001
Active Bristol

Research and experimental development on biotechnology

17 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Z

ZIHIPP LTD

08341001

Research and experimental development on biotechnology

Founded 24 Dec 2012 Active Bristol, United Kingdom 17 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Due 30 Sept 2026 3 months remaining
Confirmation Submitted 5 Jan 2026 Next due 7 Jan 2027 6 months remaining
Net assets £44M £41M 2024 year on year
Total assets £46M £42M 2024 year on year
Total Liabilities £1M £877K 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

5th Floor Halo Counterslip Bristol BS1 6AJ United Kingdom

Website

www.example.com

Full company profile for ZIHIPP LTD (08341001), an active life sciences and medical technology company based in Bristol, United Kingdom. Incorporated 24 Dec 2012. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2018–2024)

Cash in Bank

£45.22M

Increased by £41.84M (+1238%)

Net Assets

£44.20M

Increased by £40.93M (+1251%)

Total Liabilities

£1.40M

Increased by £877.04k (+169%)

Turnover

N/A

Employees

17

Increased by 6 (+55%)

Debt Ratio

3%

Decreased by 11 (-79%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (3)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jan 2020Series A
Investor 2Jan 2020Series A
Investor 3Jan 2020Series A

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 105 Shares £82.68m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
18 Dec 2024105£82.68m£787k

Officers

Officers

3 active
Status
Minnion, James StephenDirectorBritishUnited Kingdom464 Mar 2026Active
Stephen Robert BloomDirectorBritishEngland8324 Dec 2012Active
Tamsin Jane BerryDirectorBritishUnited Kingdom4522 Sept 2023Active

Shareholders

Shareholders (1)

Metsera Inc
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 3 Ceased

Pfizer Inc

Unknown

Active
Notified 13 Nov 2025
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors
Ceased

Professorstephen Robert Bloom

Ceased 13 Nov 2018

Ceased
Ceased

Group Structure

Group Structure

ZIHIPP LTD Current Company
METSERA LIMITED united kingdom

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
12 Mar 2026MortgageMortgage Satisfy Charge Full
11 Mar 2026OfficersAppointment of James Stephen Minnion as director on 4 Mar 2026
5 Jan 2026Confirmation StatementConfirmation statement made on 24 Dec 2025 with no updates
17 Nov 2025Persons With Significant ControlPfizer Inc notified as a person with significant control
14 Nov 2025Persons With Significant ControlWithdrawal Of A Person With Significant Control Statement
12 Mar 2026 Mortgage

Mortgage Satisfy Charge Full

11 Mar 2026 Officers

Appointment of James Stephen Minnion as director on 4 Mar 2026

5 Jan 2026 Confirmation Statement

Confirmation statement made on 24 Dec 2025 with no updates

17 Nov 2025 Persons With Significant Control

Pfizer Inc notified as a person with significant control

14 Nov 2025 Persons With Significant Control

Withdrawal Of A Person With Significant Control Statement

Recent Activity

Latest Activity

Mortgage Satisfy Charge Full

3 months ago on 12 Mar 2026

Appointment of James Stephen Minnion as director on 4 Mar 2026

3 months ago on 11 Mar 2026

Confirmation statement made on 24 Dec 2025 with no updates

5 months ago on 5 Jan 2026

Pfizer Inc notified as a person with significant control

7 months ago on 17 Nov 2025

Withdrawal Of A Person With Significant Control Statement

7 months ago on 14 Nov 2025